Pacira BioSciences
PCRX
PCRX
208 hedge funds and large institutions have $1.69B invested in Pacira BioSciences in 2018 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 69 increasing their positions, 76 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
208
Holders Change
+21
Holders Change %
+11.23%
% of All Funds
4.64%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
41
Increased
69
Reduced
76
Closed
18
Calls
$31.3M
Puts
$7.81M
Net Calls
+$23.5M
Net Calls Change
+$25.5M
Top Buyers
| 1 |
HM
HealthCor Management
New York
|
$107M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
$26.2M |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
$25.8M |
| 4 |
Renaissance Technologies
New York
|
$15.3M |
| 5 |
D.E. Shaw & Co
New York
|
$16M |
